Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii
Open Access
- 5 July 2010
- journal article
- Published by Wiley in Plant Biotechnology Journal
- Vol. 8 (6), 719-733
- https://doi.org/10.1111/j.1467-7652.2010.00503.x
Abstract
Recombinant proteins are widely used today in many industries, including the biopharmaceutical industry, and can be expressed in bacteria, yeasts, mammalian and insect cell cultures, or in transgenic plants and animals. In addition, transgenic algae have also been shown to support recombinant protein expression, both from the nuclear and chloroplast genomes. However, to date, there are only a few reports on recombinant proteins expressed in the algal chloroplast. It is unclear whether this is because of few attempts or of limitations of the system that preclude expression of many proteins. Thus, we sought to assess the versatility of transgenic algae as a recombinant protein production platform. To do this, we tested whether the algal chloroplast could support the expression of a diverse set of current or potential human therapeutic proteins. Of the seven proteins chosen, >50% expressed at levels sufficient for commercial production. Three expressed at 2%–3% of total soluble protein, while a forth protein accumulated to similar levels when translationally fused to a well-expressed serum amyloid protein. All of the algal chloroplast-expressed proteins are soluble and showed biological activity comparable to that of the same proteins expressed using traditional production platforms. Thus, the success rate, expression levels, and bioactivity achieved demonstrate the utility of Chlamydomonas reinhardtii as a robust platform for human therapeutic protein production.Keywords
This publication has 72 references indexed in Scilit:
- Chloroplast-Derived Vaccine Antigens and Biopharmaceuticals: Expression, Folding, Assembly and FunctionalityPublished by Springer Science and Business Media LLC ,2009
- VEGF as a potential target for therapeutic intervention in depressionCurrent Opinion in Pharmacology, 2008
- High Mobility Group Protein B1 Is an Activator of Apoptotic Response to Antimetabolite DrugsMolecular Pharmacology, 2007
- Exceptional paternal inheritance of plastids in Arabidopsis suggests that low‐frequency leakage of plastids via pollen may be universal in plantsThe Plant Journal, 2007
- Expression of cholera toxin B–proinsulin fusion protein in lettuce and tobacco chloroplasts – oral administration protects against development of insulitis in non‐obese diabetic micePlant Biotechnology Journal, 2007
- Exceptional transmission of plastids and mitochondria from the transplastomic pollen parent and its impact on transgene containmentProceedings of the National Academy of Sciences, 2007
- Determining the transgene containment level provided by chloroplast transformationProceedings of the National Academy of Sciences, 2007
- Heparin-II Domain of Fibronectin Is a Vascular Endothelial Growth Factor-Binding DomainCirculation Research, 2006
- A chloroplast transgenic approach to hyper‐express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradationPlant Biotechnology Journal, 2003
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001